NIH-funded research R21 grant

New methods for testing multiple treatments at once

Official title: Novel designs for multi-arm multi-dose multi-stage platform trials

Funded at University of Tx Md Anderson Can Ctr · NIH-11032291 · Data updated 2026-11-12

This study is looking at new ways to test multiple treatments at the same time to help speed up the process of finding effective drugs for complex diseases like Alzheimer's and cancer, so patients can get access to better options more quickly.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Tx Md Anderson Can Ctr
NIH-funded
Lab location1 site (Houston, United States)
Project startJanuary 1, 2025
Project endDecember 31, 2026
Funding year2025
Award (this year)$183,938
NIH project number1R21LM014699-01
Project IDNIH-11032291 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation would include individuals diagnosed with Alzheimer's disease or other complex conditions being targeted by the trial.

Less likely to help

Patients with conditions not addressed by the trial or those who do not meet the specific eligibility criteria may not benefit from this research.

What this research studies

This research focuses on improving the drug development process by using innovative trial designs that allow for the simultaneous evaluation of multiple treatments. By employing a multi-arm multi-stage platform trial approach, the research aims to enhance the efficiency of clinical trials, particularly for complex diseases like Alzheimer's and cancer. Patients may benefit from faster access to effective treatments as the trials can adapt based on real-time results, potentially reducing the time and resources needed for drug approval.

Why it matters

Potential benefit: If successful, this research could lead to quicker and more effective treatment options for patients with complex diseases.

How similar studies have gone: Previous research has shown that multi-arm trials can improve the efficiency of drug development, suggesting a promising avenue for this novel approach.

Where this research is happening

  • University of Tx Md Anderson Can Ctr
    Houston, United States
    Active

Researchers

  • Principal investigator: Lin, Ruitao — University of Tx Md Anderson Can Ctr
  • Study coordinator: Lin, Ruitao

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.